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Semiconductor nanocrystals (NCs) are increasingly being used as photoluminescen markers in biological imaging. Their bright-
ness, large Stokes shift, and high photostability compared to organic ﬂuorophores permit the exploration of biological phenomena
at the single-molecule scale with superior temporal resolution and spatial precision. NCs have predominantly been used as extra-
cellular markers for tagging and tracking membrane proteins. Successful internalization and intracellular labelling with NCs have
been demonstrated for both ﬁxed immunolabelled and live cells. However, the precise localization and subcellular compartment
labelled are less clear. Generally, live cell studies are limited by the requirement of fairly invasive protocols for loading NCs and
the relatively large size of NCs compared to the cellular machinery, along with the subsequent sequestration of NCs in endo-
somal/lysosomal compartments. For long-period observation the potential cytotoxicity of cytoplasmically loaded NCs must be
evaluated. This review focuses on the challenges of intracellular uses of NCs.
Copyright © 2007 Camilla Luccardini et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Semiconductor nanocrystals (NCs) “quantum dots” are in-
creasingly being used in a wide range of biomedical applica-
tions, from cell biology to medical diagnostics. They have a
core diameter of 2–10nm and signiﬁcantly larger hydrody-
namic diameter, making them suitable as large yet relatively
biocompatible markers, and have remarkable photophysi-
cal properties related to quantum conﬁnement eﬀects [1].
Their superior brightness, higher photostability, and nar-
rower spectral emission compared to conventional organic
ﬂuorophores have progressively lead biophysicists to adopt
them as a new tool for single-molecule imaging, in vitro
and in vivo. NCs have become an alternative for organic
ﬂuorophores and complementary tool of ﬂuorescent pro-
teinsinsingle-moleculeﬂuorescenceandwhole-celllabelling
assays.
In this review, we focus on the intracellular applications
of semiconductor nanocrystals in biological imaging. We
ﬁrst discuss their unique optical properties, we then intro-
duce some considerations on their surface chemistry and we
explore in the following sections the diﬀerent possible strate-
gies to deliver NC inside the cell and to speciﬁcally target
them to a protein of interest. Finally, we report on recent ap-
plications of NCs in whole animal imaging in vivo and ad-
dress the risk of potential cytotoxicity.
2. CHEMICAL AND OPTICAL PROPERTIES
NCs are inorganic particles of 200 to 1000 atoms. NC cores
are commonly synthesized from group II-VI (e.g., CdSe,
CdS, ZnSe, and CdTe) and III-V (e.g., InAs, InP, and PbS)
semiconductor materials. For any energy exceeding the band
gap, which depends on the core diameter, absorption of2 Journal of Biomedicine and Biotechnology
a photon generates an electron-hole pair, which on recom-
bination results in the emission of a less-energetic photon.
Due to their broad absorption spectra, NCs can eﬃciently be
excited with a multitude of laser lines. Variations in the par-
ticle composition and size result in diﬀerent band-gap ener-
gies and hence NCs diﬀerent photoluminescent (PL) emis-
sion, ranging from the near UV to the IR (400–1350nm)
[2]. NCs have narrow and symmetric photoluminescence
(PL) emission peaks with typical full widths at half maxi-
mum (FWHM) of 25–35nm [3] that facilitate multicolour
imaging by allowing eﬃcient single-colour excitation whilst
minimizing emission cross-talk [4], see [5]f o rac r i t i c a ld i s -
cussion. Unlike with organic dyes, the PL emission arises
from the radiative recombination of an exciton. For NCs, re-
laxation to the ground state takes ∼10 nanoseconds, about
oneorderofmagnitudelongerthansinglet-singlet electronic
transitionsinorganicﬂuorophores.TheslowPLdecaymakes
NCs attractive sources for time-gated imaging, which can be
used to reduce the relative contribution of cellular autoﬂuo-
rescence to the total collected signal [6]. Figure 1 graphs the
evolutionofthecollectedfractionoflong-livedNCemission,
relative to that of the short-lived autoﬂuorescence for diﬀer-
ent time gates Δt at a ﬁxed lifetime ratio of 1:10. Larger gates
are required to attain the same suppression of background
for increasing levels of autoﬂuorescence. For intensity-based
detection NCs beneﬁt from their large brightness (εφ)w h i c h
results from a 10-to-100 time larger molar extinction coeﬃ-
cients (ε∼105–106 M−1cm1) than organic dyes [7, 8]a tc o m -
parable quantum yield φ. Finally, due to their signiﬁcantly
higher photostability than organic ﬂuorophores, NCs are at-
tractiveforlong-period observation(LPO).Theresistanceto
photobleaching results from the deposition of an additional
semiconductor shell (e.g., ZnS or CdSe) having a larger band
gap than the core. The result is the conﬁnement of the ex-
citons to the core. However, NCs are not completely inert
to prolonged illumination. The photophysical properties fa-
cilitate LPO at the single-NC level, a particularly interesting
property in single-particle tracking (SPT) applications [9],
tracing cell lineage [10], and live animal imaging [11], that
all combine the demand for imaging small numbers of ﬂuo-
rophores over extended observation periods.
Beyond their established function as molecular markers,
NCs are increasingly being used for FRET-based biosensing
(see [12] for review). NCs are both a scaﬀold and central
donor for exciting multiple organic acceptor ﬂuorophores in
these inorganic/organic hybrid FRET sensors [13–16]. Also,
NCs are attractive FRET donors because, through selecting
the appropriate size, they can be dialed into almost arbitrary
acceptors. The large overlap integrals between donor emis-
sion and acceptor absorbance allow for larger FRET eﬃcien-
cies or transfer over larger donor/acceptor distances. Due to
the broad absorption bands and narrow-band emission, one
can chose excitation wavelengths minimizing direct acceptor
excitation and minimal bleed-through of donor ﬂuorescence
into the FRET detection channel.
Atthesingle-NClevel,theradiativerecombinationofthe
exciton can temporarily be prevented despite ongoing excita-
tion, resulting in intermittent PL emission, known as “blink-
ing” [17]. Blinking results from the stabilization of the exci-
ton at the NC surface and is associated with surface defects.
Dark states reduce the duty cycle, complicate the interpreta-
tion of intensity-based measurements, and prompt the elab-
oration of speciﬁc algorithms for quantitative SPT [18].
However, blinking can be turned to an advantage in as
much as it allows the identiﬁcation of single NCs and the de-
tection of single-pair FRET (spFRET, Figure 2(a)), as shown
on panel (b) between a QD565STV NC donor and an Alex-
aBiotin organic ﬂuorophore acceptor (Yakovlev, Luccardini,
and others’ personal observations). Blinking of neighboring
NCs can also be used for ultrahigh resolution studies beyond
the classical resolution limit [19] and allows the emission of
single particle to be isolated from the crowd. NC detection
is not restricted on detecting PL. Their electron density and
crystal structure provide suﬃcient contrast in transmission
electron microscopy (EM) [9, 20]. Their use in EM is an ad-
ditional advantage over labelling samples with conventional
dyes that need to be photoconverted or require the addition
of electron-dense material to generate contrast on EM im-
ages. However, the contrast obtained with NCs is lower than
when using Au nanoparticles for immunolabelling.
3. NANOCRYSTAL SURFACE CHEMISTRY
Successful cell biological applications of semiconductor NCs
had to await the development of reliable protocols for syn-
thesizing water-soluble and colloidally stable nanoparticles.
To be of use in cellular imaging, NCs need to be ﬁrst ren-
dered water-soluble and nonaggregating and then function-
alized to be speciﬁcally targeted to a molecule of interest.
They should also be stable and ideally have a long shelf life
as well as to allow for experiment series under reproducible
conditions.Thetimeneededtodeveloppotentsolubilization
and functionalization strategies justiﬁes the time elapsed af-
ter the ﬁrst proposition of NCs as biological probes [3, 22]
and their wider use by the biological community which is
only beginning. NCs are synthesised in organic solvents and
are subsequently coated with a hydrophobic shell of surfac-
tant trioctyl phospine oxide (TOPO) to maintain the parti-
cles monodispersed in organic solvents. Their water solubil-
ity is obtained by capping the NC surface with an additional
hydrophilic coating layer. Among the many solubilization
strategiesthathavebeendesignedthemosteﬃcient,interms
of colloidal stability and biocompatibility, is at present the
amphiphilic polymer coating [23–25]. Particle aggregation
can further be reduced through the addition of a polyethy-
lene glycol (PEG) layer, which also minimizes nonspeciﬁc in-
teractions [20, 26, 27]. Taken together, the improvements in
understanding NC surface chemistry and hence controlling
their colloidal properties have prompted an ever increasing
number of studies using colloidal semiconductor NCs as PL
markers in cell biological applications (see, e.g., [28, 29]f o r
review).
Theeasieraccessibilityofextracellularepitopesofcellular
membrane antigens readily motivates the increasing number
of studies using NCs instead of organic-ﬂuorophore conju-
gated antibodies as extracellular markers in immunoﬂuores-
cence [9, 30, 31]. Diﬀerent linkers have been used for func-
tionalizing NCs, including streptavidin [32–34], receptorCamilla Luccardini et al. 3
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Figure 1: Time-gated acquisition of nanocrystal photoluminescence suppresses short-lived autoﬂuorescence, [6]. (a) Schematic representa-
tion of the relative timing of the laser pulse (instantaneous, blue), along with the normalized decays of autoﬂuorescence (AF, purple, τ = 1
nanosecond), NC photoluminescence (NC, green, τ = 10 nanoseconds), and their sum (red), respectively. (b) Background rejection versus
gate time. SNR is the ratio of the integrated signal of the NC divided by the integrated signal of the AF. The numbers/colors represent 5
diﬀerent ratios INC/IAF. To obtain the same SNR at a higher level of AF, a larger time gate is required. The shift in time is relative to the
center of a sigmoidal function 1/(1 + exp (−T/t)) that describes detector gating. We assumed a detector on response (10–90%), T = 4.4
nanoseconds. Thus, at Δt = 0d e t e c t i o ne ﬃciency is 50%.
(a)














Figure 2: Use of blinking to detect single-particle ﬂuorescence resonance energy transfer (spFRET). (a) Schematic representation of the
donor/acceptor geometry consisting of a central QD565-ITK/STV donor (green) and biotinylated Alexa594 acceptor (red). NCs were im-
mobilized on glass slides using a biotin-antibody linker. (b) Time-resolved traces of PL intensity simultaneously observed in the donor
(D565/20nm) and FRET channel (D655/40nm) upon donor 440-nm excitation. The green-emitting NC donor transfers its energy to mul-
tiple orange-red ﬂuorescing acceptors. Donor bleed through and acceptor direct excitation are negligible, and contribute less than 0.5% each
to the total signal, respectively. Note the concomitant blinking in both channels, indicating no energy transfer when the quantum dot donor
is in an OFF state, a hallmark of spFRET [21]. cps = counts per second.
ligands [35, 36], peptides [37], as well as secondary [38]o r
primary antibodies [39]. The popularity of NCs for study-
ing molecular migration comes, at least in part, from the fact
that NCs often oﬀer a viable compromise between the de-
sired stability and the tolerable degree of invasiveness. On
the one hand, they are clearly more stable than small organic
ﬂuorophores that in turn exert less inﬂuence on the bound
ligand. On the other hand, over tags oﬀering a comparable
long-term stability, such as the much bigger (and hence in-
vasive) ﬂuorescent nanobeads or light-scattering gold par-
ticles [40], through their smaller size, so that NCs are less
prone to reduce ligand mobility and access to the binding
site.
Despite their obvious advantage for extracellular la-
belling, four main diﬃculties are encountered when using
NCs for intracellular labelling of cytoplasmic constituents
in live cells. First, to deliver NCs into the cell, the plasma
membrane has to be made transiently permeable for these
nanoscale (but in a cellular context yet relatively large) ob-
jects, while maintaining the cell intact and viable [41]. Sec-
ond, as NCs are also unspeciﬁcally taken up, probably by
a process similar to pinocytosis, any speciﬁc uptake has to4 Journal of Biomedicine and Biotechnology
dominate over these nonspeciﬁc uptake mechanisms to en-
sure a speciﬁc labelling. Pinocytosis occurs in all types of
cells, leading to pinosomes which can be bigger than 1μm
(macropinocytosis). Because their size, macropinosomes
provide an eﬃcient route for nonselective endocytosis of so-
lutemacromolecules,andhenceNCsinsolution.Third,once
the NCs have penetrated the cell, they must stay monodis-
persed and reach their molecular target through diﬀusion or
transport.However,nanometrichardparticlesarefrequently
recognized as exogenous objects and are engulfed in endo-
/lysosomal compartments. Finally, even in the case of a suc-
cessful cytoplasmic loading, the main obstacle remains the
diﬃculty in addressing NCs to their speciﬁc target sites and
in removing the unbound NC fraction from the cytoplasm.
4. CROSSING THE PLASMA MEMBRANE
Whole-celllabellinghasbeendemonstratedwithbiocompat-
ible, but nonfunctionalized (bare) NCs. The addition of NCs
to the extracellular medium leads to their spontaneous up-
take [28, 42]. Not only specialized macrophages and ﬁbrob-
lasts but also many cells internalize both extracellular parti-
cles and ﬂuid via phagocytosis and pinocytosis, respectively.
VirtuallyallcellsareabletotakeupNCsviaendocyticmech-
anisms. This uptake leads to endodomes that are much big-
ger than the NCs itself (macropynosomes >1μm, clathrin
coated pits ∼120nm, caveolae ∼60nm, and clathrin- and
caveolin-independent endocytosi ∼90nm [43]). However,
t h e s et r a c k so f t e nl e a dt oa g g r e g a t i o n so fN C sc r o w d e di n
intracellular compartments (recognized by the absence of
blinking). Thus, additional and more speciﬁc loading tech-
niques are required for speciﬁc NC loading.
Microinjection is a simple tool for loading monodis-
persed NCs into the cytoplasm [10, 36]. Dubertret and
coworkers injected NCs into Xenopus laevis oocytes and
traced the cell lineage throughout embryonic development.
Single-cell electroporation [44] potentially is another tech-
nique for loading charged NCs into individual cells, but its
eﬃciency critically depends on the size and charge of NCs
(Luccardini and Yakovlev unpublished observations). How-
ever, similar to patch clamping or microinjection, it is time-
consuming techniques; and more eﬃcient techniques are de-
sirable when the loading of larger cell populations is re-
quired.
Bulk electroporation of cell suspensions allows the paral-
lel delivery of NCs into thousands of cells, but has been re-
ported to go along with NC aggregation [36, 45]. This tech-
nique probably traps NCs on the plasma membrane where
they are endocytoted during the time that is required for the
cells to settle on the cover glass before imaging (Luccardini
and Yakovlev, personal observations). Thus, the osmotic ly-
sis of pinosomes (Figure 3, upper panel) provides a simple
and convenient method to eﬃciently load monodispersed
NCs into many cells simultaneously, under identical condi-
tions. During loading, the cell morphology did not change
and plasma membrane integrity and cell viability were not
aﬀected through the osmotic shock and inclusion of NCs
(Figure 3, lower panel). This technique enabled, for exam-
ple, the loading of NCs to track single kinesin motors in
live cells [46]. Chemical methods to deliver NCs to the cy-
toplasm include the use of cationic polymers [36, 45, 47]
and cationic lipids [10, 48]. After liposome formation, NCs
penetrate the plasma membrane, but accumulation in en-
dosomal compartments is frequently observed [36, 39, 49].
Also, liposome-loaded NCs have been found in late endo-
somes/lysosomes [50], and in keeping with this observation,
tend to concentrate in regions close to the nucleus [10].
Overcoming NC sequestration, encapsulation of NCs in a
PEG-graftedpolyethyleniminecoathasbeenreportedtoper-
mit their escape from endosomal compartments [51]. An-
other possibility for NCs delivery into the cytosol is their
conjugation to speciﬁc peptide sequences [52, 53], similar to
what has been used for the delivery of magnetic nanoparti-
cles [54]. Although this is a particularly interesting and ac-
tive area of research, and NC translocation to the cytoplasm
[55, 56] and speciﬁc labelling of intracellular organelles such
as mitochondria [36, 57] or the nucleus [36, 45]h a v eb e e n
published, the true impact of these studies can only be eval-
uated with a careful study of the three-dimensional (3-D)
intracellular localization of the NCs, for example, combin-
ing speciﬁc immunostaining and quantitative 3D imaging
[35, 58], and careful colocalization analysis [5]. Finally, the
conjugation of NCs to membrane-permeable toxins like bo-
tulinum toxin should represent an attractive strategy to de-
liver NC into the cytoplasm, although further work needs to
conﬁrm these initial observations.
In summary, while many diﬀerent strategies of NC load-
ing have been explored and some of them to produce a
monodispersed cytoplasmic labelling at least in the cell types
studied, the absence of rigorous criteria for successful cyto-
plasmic loading and the lack of appropriate controls along
with the often uncritical and overoptimistic interpretation of
intracellular ﬂuorescent puncta make it hard to be directly
extrapolated from the published literature on the own ex-
periment. In principle, if NCs are localized in the cytoplasm
rather than sequestered in some intracellular compartment,
they should be evenly distributed in and randomly diﬀused
throughout the accessible volume; in contrast, many images
rather show localized distributions and heterogeneous clus-
ters of diﬀerent sizes and brightnesses. A deﬁnite proof needs
SPT and the analysis of single molecule ﬂuorescence. Blink-
ing and consistent diﬀusion coeﬃcients will clarify if parti-
clesaremonodispersedandtrappedortheycandiﬀusefreely.
As yet, it seems safe to say that the uptake and internalization
of nanoscale particles into cells has not been completely un-
derstood and probably varies both from cell type to cell type.
Also, it depends on the surface chemistry of the nanoparti-
cles. Additionally, puriﬁcation steps could play a crucial role;
for example, in determining the concentration of excess lig-
ands in solution.
5. REACHING SPECIFIC INTRACELLULAR TARGETS
Site-speciﬁc labelling of intracellular proteins is far more
diﬃcult than extracellular target recognition, since the
cytoplasm constitutes a crowded molecular environment,
containing a plethora of proteins, nucleic acids, and





to hypotonic culture medium caused the osmotic lysis of the internalized pinosomes and release of NCs into the cytoplasm. (a) Bright-ﬁeld
image at ×100 magniﬁcation. Scale bar for (a) to (c): 4μm. (b)–(c) Epiﬂuorescence images from a time-resolved image stack of the same
cell. Green circles identify individual NCs that intermittently changed from ON to OFF state (blinking) between frame 250 (b) and 253 (c).
Cell viability following loading was tested using the trypan blue exclusion assay at low magniﬁcation, ×10. Osmotic shock without (d) and
with 1nM QD565ITK nanocrystals in the extracellular ﬂuid (e) did not compromise cell viability. (f) In contrast, adding ethanol reliably
killed cells as reported by the dark trypan blue labelling. Scale bar for (d) to (f): 40μm.
targeting, tagging strategies rely on speciﬁc target recogni-
tion (reviewed in [12, 59]). Another requirement for LPO
imaging is that the chemical bond linking the cytoplasmic
target and the label chosen for its detection is stable over the
experiment time.
It is in response to this need that the Tsien laboratory
(University of California, Calif, USA) introduced genetically
encoded ﬂuorescent proteins in cell biology (reviewed in
[60]). An alternative strategy uses self-labelling protein tags.
The introduction of a small protein tag or of a unique com-
bination of amino acids on the target protein allows their in-
teraction with a speciﬁc ﬂuorophore-bearing substrate, here
an NC. Examples of self-labelling protein tags are biarseni-
cal compounds [61, 62], SNAP tag [63], and Halo tag [64].
These approaches are helpful for developing new NC func-
tionalization strategies for speciﬁc intracellular targeting.
6. WHOLE ANIMAL IMAGING, IN VIVO
Comparedwithapplicationstosubcellularimagingincellbi-
ology, NC-based whole-animal imaging has developed very
fast [65]. Due to their long-wavelength emission, bright-
ness, and long-term photostability, NCs are ideal probes for
sensitive in vivoimaging in deep tissues of small animals
or imaging superﬁcial tissue layers of larger species [11].
The possibility of synthesizing NCs emitting in the infrared
wavelengths minimizes scattering, optimizes depth penetra-
tion and allows discrimination against collagen autoﬂuores-
cenceandthusshouldpermitultradeepimagingof“optically
thick” tissue [66, 67], provided that cytotoxicity is not an is-
s u e( s e eS e c t i o n7).
One of the ﬁrst live-animal applications of NCs was the
selective labelling of tumor vasculature in mice by using PE-
Gylated NCs coated with speciﬁc peptidic sequences against
vascular markers. In 2002 ˚ Akerman et al. [26]s h o w e di nh i s -
tological staining that after intravenous NC injection, func-
tionalized NCs can be addressed to speciﬁc blood vessels.
A high level of PEG substitution on top of the functional-
ization of the NCs reduced their uptake into the endothe-
lial reticulum. One year later, Larson et al. were able to im-
age by multiphoton microscopy NCs through the skin of
live mice, in capillaries embedded 100μmi nt i s s u e[ 4]. Bal-
lou et al. demonstrated the importance of long-chain PEG
(5kDa) coating for increasing the duration of NCs circulat-
ing in the blood ﬂow of mice [20]. They were able to detect
NCs by noninvasive whole body ﬂuorescent imaging, upto
four months after injection. The same report also showed
thatNCsdepositinliver,skin,andbonemarrowinasurface-
coating dependent manner and that polymer- and PEG-
coated (upto 3,400Da MW) NCs are cleared from the blood
after injection. Gao et al. developed polymer-coated NCs
functionalized with a monoclonal antibody directed against
prostate cancer cells as a cell-speciﬁc marker [68]. After NC
injection in mice, transplanted with human cancer prostate
cells, they succeeded in speciﬁcally detecting and imaging
the tumor site. However, as their NCs emitted in the visi-
blespectrum,theauthorsusedspectralunmixing algorithms
to detect the NC signal in the presence of autoﬂuorescence.
Alongtheselines,Kimetal.[11]intradermallyinjectednear-
infrared-emitting NCs in mice and pigs and imaged sen-
tinel lymph nodes (SNL) one cm deep in tissue. This work
enables for the ﬁrst time SNL mapping and cancer surgery
under image guidance. Metastatic tumor cell extravasations6 Journal of Biomedicine and Biotechnology
were monitored in mice by intravenous injection of cells la-
belled with NC, which were examined by ﬂuorescence emis-
sion spectroscopy [47]. More recently, Stroh et al. combined
NCs and multiphoton intravital microscopy to distinguish
in mice tumor vessels from perivascular cells and extracel-
lular matrix [48]. With this approach, they also investigated
the ability of NC-loaded silica beads (100–500nm diameter)
to access the tumor and monitored the traﬃcking of the pre-
cursorcells,apromisingtechniqueforcancerpreventionand
treatment.
So et al. designed recently “self-illuminating” NC conju-
gates permitting in vivo imaging without an external light
source; instead, luciferase on the NC surface transfers its ex-
citation to the NC core in a Bioluminescence resonance en-
ergy transfer (BRET) assay [69]. Intramuscular or subcuta-
neous injection in mice of 5 pmol of polymer-coated NCs
conjugated to the Renilla reniformis luciferase was enough to
image a BRET emanating from 3mm depth tissue, after coe-
lenterazine injection for activation. We note that this study is
one of the few applications that used NCs as acceptors rather
than donors.
7. CYTOTOXICITY
As NCs are increasingly being used as biological photolumi-
nescent probes, in both acute cell assays and chronic, in the
entire animal, in vivo, it is important to evaluate if they rep-
resent a speciﬁc risk of toxicity for the organism under study.
Although probably not classically termed cytotoxicity
in a strict sense, one obvious problem resulting from the
nanoscopic size of nanoparticles is that NCs can directly af-
fect the biological system under study by impairing the mo-
bility, interaction, binding, or other biological action of the
ligand molecule to which they are attached. Hence, any study
using NC-conjugated biomolecules must exclude the inhibi-
tion of the enzyme, receptor, motor, or other by the NC.
Concerns against the use of semiconductor NCs for cell
biological applications go well beyond arguments of steric
hindrance. It is well known that Cd2+ can be released from
the CdSe core after oxydative attack (corrosion) [70]. Bare
CdSe NCs are particularly harmful in this regard [36, 71],
limiting their utility for direct-injection strategies. Addi-
tional shells (ZnS) and capping (silanization) can reduce
Cd2+ leakage, and further puriﬁcation steps can remove al-
ready released Cd2+ [71–73]. In our hands, a supplementary
puriﬁcationsteppriortoloadingNCreducesthetoxicaction
of NCs [74], as measured by a resazurin or cell adhesion as-
say (Figure 4). Nevertheless, it is important to bear in mind
that despite sporadic claims of nanoparticles being indis-
criminately harmless [57], there is a general consensus that
NC are toxic and that their toxicity depends on their con-
centration, precise chemical composition, the particle size,
colloidal stability, as well as solubilization and functionaliza-
tion groups. Also, CdSe particles are generally more toxic
inside the cell than extracellularly, in line with the known
action of Cd2+ by inhibiting protein synthesis, carbohydrate
metabolismand—withtime—byitsaccumulationinkidney
and liver [75]. At the same time, the undisputable cytotoxic
action of Cd nanoparticles has not precluded acute staining











Figure 4: Experimental evaluation of cytotoxicity of polymer-
coated CdSe nanoparticles. Toxicity to NIH-3T3 ﬁbroblasts of a
NC-containing solution was estimated after 48-hour application.
Dose-response curve for cell viability was measured with a Re-
sazurin assay [74]. Reazurin is a nonﬂuorescent dye that is me-
tabolized in functional mitochondria and converted into resoruﬁn
which ﬂuoresces red. Black and grey curves show two experiments
(n = 8 measurements each). Normalized survival R(c) after applica-
tionofaCd2+ concentrationc(Cd)wasestimatedfromthechangein
absorbance of the converted dye measured at 600nm. Changes in R
became signiﬁcant at c (Cd) around 3–5μM, whereby c (Cd) refers
to the concentration of Cd2+ on the surface of the CdSe nanoparti-
cles, which accounts for the diﬀerent toxicity of diﬀerent-size NCs.
This concentration of Cd2+ corresponds to a concentration of CdSe
nanoparticles of 50-70nm. Similar data was obtained with a cell
adhesion assay [71] (not shown). In contrast for free cobalt ions
(Co2+), cytotoxic eﬀects became signiﬁcant at around 50μM( d a t a
not shown).
experiments of cells, because the concentration of NCs can
be always kept low enough to prevent immediate cytotoxic
damage within the experimental time window, but still high
enough for enough ﬂuorescence [4, 20, 39, 45, 47, 50]. How-
ever, because of the ligand desorption over time, a simple
ligand exchange functionalization is not eﬀective to durably
prevent intracellular NC degradation. Since as much as NCs
are intrinsically colloidally unstable and cytotoxic for cells
[76], the speciﬁc kind of coating is essential for at least re-
tarding the cytotoxic eﬀect [29, 36, 73]. PEG coating can re-
ducetheunspeciﬁcuptakeofNCs,itreducestheirtoxiceﬀect
for extracellular application at the same initial concentration
[29, 71].
For biomedical applications as well as chronic animal
experiments, the major healthcare concern of NC labelling
is related to the leakage of Cd2+ into the organism, even
at low dose. Extracellular application of CdSe particles al-
ready presents a cytotoxic risk because Cd2+ does not only
block Ca2+ ion channels (like Co2+ as well, which is released
from magnetic NCs) but also it permeates through the chan-
nel and enters the cytoplasm. We note that the absence of
a visible eﬀect, often based on the detection of cell mor-
phology changes and cell viability assays does not exclude
a cumulative poisoning of the organism which ﬁrst impairs
the metabolism of the cells, without being immediately nox-
ious. Interestingly, a similar debate has long haunted the
evaluation of nonlinear photodamage caused by two-photon
ﬂuorescence excitation, where the introduction of rigorousCamilla Luccardini et al. 7
physiologically relevant criteria based on microscopic ob-
servables like the kinetics of Ca2+ transients [77, 78]h a s
ended the futile discussion.
In conclusion, more work is needed to critically evaluate
the cytotoxicity of NCs, both upon short- and long-term ex-
posure. To better understand the deleterious action of diﬀer-
ent NCs on the organism under study, standardized samples,
experimental conditions, cells, and assays would be a great
leap forward and pave the ground for biomedical applica-
tions that would additionally beneﬁt from a tight collabora-
tion with toxicologists.
8. CONCLUSIONS
In this review, we focus on nanocrystal applications in vivo,
both in cell biology and medical diagnostics, and on the po-
tential toxicity of NCs for biological imaging. The advances
in understanding NC colloidal properties together with the
ability of developing stable surface chemistries has brought
about a large choice of functionalization strategies which
now oﬀer to biologists a versatile tool kit for many appli-
cations that rely on ﬂuorescence and electron microscopy.
The main advantages of NCs over conventional organic ﬂuo-
rophores are the possibility to detect easily single molecules,
mostly derived from their superior brightness and the long-
term photostability; the spectral tunability and narrow-band
emission; and, going along with these, the ease of NC use in
multicolour ﬂuorescence. However, nanoparticles are not a
cure-all. Particularly Cd-based NCs are potentially cytotoxic,
and the modulation of their optical properties (e.g., their in-
trinsic ﬂuorescence intermittency) through their local chem-
ical environment (see, e.g., [79]) needs to be considered in
each application.
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